Type 1 Diabetes Clinical Trials

57 studies are recruiting for type 1 diabetes in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Aurora, Colorado 10 Indianapolis, Indiana 7 Boston, Massachusetts 6 Gainesville, Florida 6 Seattle, Washington 6 Atlanta, Georgia 5 Buffalo, New York 5 Columbus, Ohio 5 Miami, Florida 5 New Haven, Connecticut 5 New York, New York 5 San Francisco, California 5 Chicago, Illinois 4 Houston, Texas 4 Kansas City, Missouri 4 Nashville, Tennessee 4 Baltimore, Maryland 3 Charlottesville, Virginia 3 Dallas, Texas 3 Jacksonville, Florida 3 Philadelphia, Pennsylvania 3 Pittsburgh, Pennsylvania 3

Studies, page 3

  1. MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes

    Diabetic kidney disease and cardiovascular disease remain the leading causes of morbidity and mortality in people with type 1 diabetes and are exacerbated with longer duration of diabetes and time outside goal glycemic range. Yet, type 1 diabetes is a complex disease with pathophysiology that exten…

    Stage
    Phase 1
    Ages
    12 to 25
    Site
    Seattle Children's Hospital, Seattle, Washington
    Locations
    2 in total
    Run by
    Kalie Tommerdahl

    See if you can join NCT05065372 on ClinicalTrials.gov

  2. Closed Loop Context Aware AID

    An artificial pancreas (AP) is a control system for automatic insulin delivery. The investigators have implemented a high blood sugar detection and dosing algorithm for use within an AP control system. If a high blood sugar pattern is detected, correction insulin will be calculated and delivered. T…

    Stage
    Not phased
    Ages
    18 to 100
    Site
    Oregon Health and Science University, Portland, Oregon
    Run by
    Oregon Health and Science University

    See if you can join NCT06676657 on ClinicalTrials.gov

  3. Type 1 Diabetes, Endothelin, and Skeletal Muscle Mitochondrial Dysfunction: The Role of Sirtuin-1

    The proposed study is designed to test the hypothesis that treatment of resveratrol for 12 weeks will improve both endothelin-B receptor (aim 1) and skeletal muscle mitochondrial function (aim 2) in people with type 1 diabetes.

    Stage
    EARLY_Phase 1
    Ages
    18 and older
    Site
    Augusta University/Georgia Prevention Institute/ Laboratory of Integrative and Exercise Physiology, Augusta, Georgia
    Run by
    Augusta University

    See if you can join NCT04449198 on ClinicalTrials.gov

  4. Using Simplified Meal Boluses Versus Carbohydrate Counting in Adolescents With Hybrid Closed Loop Systems

    The goal of this trial is to evaluate blood sugar control in patients with type 1 diabetes when using a simple meal bolus strategy (small, medium, large meals) compared to carbohydrate counting when on a hybrid closed loop system. The main question it aims to answer are: What is the blood sugar tim…

    Stage
    Not phased
    Ages
    14 to 26
    Site
    Barbara Davis Center, Aurora, Colorado
    Run by
    University of Colorado, Denver

    See if you can join NCT06575790 on ClinicalTrials.gov

  5. Skeletal Effects of Type 1 Diabetes on Low-Trauma Fracture Risk

    Patients with Type 1 Diabetes Mellitus (T1DM) have a higher risk of low-trauma (osteoporotic) fracture that is 7-12 times higher than non-diabetics. The bone density of people with Type 1 Diabetes is higher at the time of fracture than in non-diabetics. This suggests the presence of underlying bone…

    Stage
    Not phased
    Ages
    50 and older
    Site
    Creighton University Osteoporosis Research Center, Omaha, Nebraska
    Run by
    Creighton University

    See if you can join NCT05701254 on ClinicalTrials.gov

  6. PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life

    This research study is called 'PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life: The PROMISE Study'. The purpose of this study is to find out more about how exposures during pregnancy, such as having an infection, diet and growth may impact later risk of type 1 diabe…

    Stage
    Not phased
    Ages
    0 to 99
    Site
    University of Colorado, Aurora, Colorado
    Locations
    4 in total
    Run by
    University of Colorado, Denver

    See if you can join NCT06141434 on ClinicalTrials.gov

  7. The T1D Exchange Registry

    The T1D Exchange Registry is a research study, conducted over time, for individuals with type 1 diabetes and their supporters. Participants volunteer to provide their data for research (for example, by answering questions in annual surveys). Once enrolled, Registry participants have the opportunity…

    Stage
    Not phased
    Ages
    Any age
    Site
    T1D Exchange, Boston, Massachusetts
    Run by
    T1D Exchange, United States

    See if you can join NCT04629586 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.